Aktis Oncology, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2021

Location

Boston MA US

Primary Industry

Biotechnology

About

Founded in 2021 and based in Massachusetts, US, Aktis Oncology, Inc. was co-founded by Mr. Brian Goodman, Mr. Patrick Baeuerle, and Mr. Todd Foley of MPM Capital. The company’s team of entrepreneurs and drug developers develops platforms to discover tumor-targeting agents for delivering alpha radiotherapy. The company generates revenue through the sale of the developed therapies to pharmaceutical companies. The company plans to create multiple platforms to target tumor cancers.

Current Investors

MPM BioImpact, Bristol-Myers Squibb Company, EcoR1 Capital

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.aktisoncology.com

Company Stage

Series B

Total Amount Raised

Subscriber access only

Key Contacts

Name	Position	Start Date	End Date	Vcard	Bio
	Board Member						BM

BM Board Member

Name	Firm	Deal Date	Number Of Deals	Vcard
						AI LP
						AI LP

AI Active Investor LP Lead Provider

Want to see more?

Request a demo for full access to this profile.

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.